A review of methods of drug cost management in hospitals

Journal of Clinical Pharmacy and Therapeutics

Volumn 23, Issue 3, 1998, Pages 171-177

  Pacey, S ^a   Po, A Li Wan ^b  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST CONTROL; DRUG COST; HOSPITAL PHARMACY; MANAGEMENT; PHARMACIST;

COST CONTROL; DRUG COSTS; GREAT BRITAIN; HOSPITAL COSTS; PHARMACY AND THERAPEUTICS COMMITTEE; PRESCRIPTIONS, DRUG;

EID: 7844248271     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.1998.00140.x     Document Type: Article

References (73)

1. Office of Health Economics (OHE) (1995) Compendium of Health Statistics. 9th edn. OHE, London.
2. Freemantle N, Bloor K. (1996) Lessons from international experience in controlling pharmaceutical expenditure I: influencing patients. British Medical Journal, 312, 1469-1471.
3. Bloor K, Freemantle N. (1996) Lessons from international experience in controlling pharmaceutical expenditure II: influencing doctors. British Medical Journal, 312, 1525-1527.
4. Bloor K, Maynard A, Freemantle N. (1996) Lessons from international experience in controlling pharmaceutical expenditure III: regulating industry. British Medical Journal, 313, 33-35.
5. Anon. (1990) Implementing a local prescribing policy. Drug and Therapeutics Bulletin, 28, 93-95.
6. Garvey G, Jappy B, Stewart D, et al. (1990) Grampian health boards' joint drug formulary. British Medical Journal, 301, 851-852.
7. Ferrow L, Hickey FM, Jappy B, Petrie JC, Reid JP, Williams A. (1997) The Grampian Joint General Practice/Hospital Formulary - an update. Pharmacy Journal, 257, 124-125.
8. Sutters CA. (1989) Peer group review of drugs - the way forward. Pharmacy Journal, 243, 246-248.
9. Weintraub M. (1990) Formulary review: an ongoing process. Pharmacy and Therapeutics, 15, 847-848.
10. Feely J, Chan R, Cocoman L, Mulpeter K, O'Connor P. (1990) Hospital formularies: need for continuous intervention. British Medical Journal, 300, 28-30.
11. Karr A, Shulman R, Drayan S. (1996) Promoting a drug formulary. Pharmacy Journal, 256, 656-657.
12. Pearce MJ, Begg EJ. (1994) Hospital drug therapy cost containment through a preferred medicines list and drug utilisation review system. New Zealand Journal of Medicine, 107, 101-104.
13. Baker JA, Lant AF, Sutters CA. (1988) Seventeen years' experience of a voluntarily based drug rationalisation programme in hospital. British Medical Journal, 297, 465-469.
14. Swallow RD, Remington H, St C, Standing VF. (1985) Ward pharmacy: a positive contribution to cost control? Pharmaceutical Journal, 235, 722-723.
15. Collier J, Foster J. (1985) Management of a restricted drugs policy in hospital: the first five years' experience. Lancet, 8424, 331-333.
16. Hazlet TK, Hu T-W. (1992) Association between formulary strategies and hospital drug expenditures. American Journal of Hospital Pharmacy, 49, 2207-2210.
17. Plumridge RJ, Stoelwinder JU, Berbatis CG. (1984) Improving patient care and pharmacy management: the effect of hospital formularies. Drug Intelligence Clinical Pharmacy, 18, 652-656.
18. Pearce MJ, Begg EJ. (1992) A review of limited lists and formularies: are they cost effective? Pharmacoeconomics, 1, 191-202.
19. Abramowitz, PW. (1984) Controlling financial variables-changing prescribing patterns. American Journal of Hospital Pharmacy, 41, 503-515.
20. Abramowitz PW. (1984) Controlling financial variables-purchasing, inventory control and waste reduction. American Journal of Hospital Pharmacy, 41, 309-317.
21. Remington H. (1945) Recycling patients' own medication reducing wastage and drug costs. Pharmacoeconomics, 8, 469-472.
22. Brown AW, Barrett CW, Herxheimer A. (1975) Hospital pharmacy committees in England: their structure, function and development. British Medical Journal, 1, 323-326.
23. Wilson JV, Hawkey CJ. (1990) Drugs and Therapeutics committees in the UK: 81-87. British Journal of Pharmaceutical Practice, 12, 198-205.
24. Department of Health HC(88). (1988) The Way Forward for Hospital pharmaceutical Services. HMSO, London.
25. NHS Executive/Department of Health. EL(94) 72. (1994) Purchasing and Prescribing. HMSO, London.
26. Slavick HE, Simon LS. (1984) Cost containment efforts of pharmacy and therapeutics committee. Quality Review Bulletin, 10, 38-41.
27. Hochla PKO, Tuason VB. (1992) Pharmacy and Therapeutics committee cost containment considerations. Archives of Internal Medicine, 152, 1773-1775.
28. Ioannides-Demos LL, Eckert GM, McLean AJ. (1992) Pharmacoeconomic consequences of measurement and modification of hospital drug use. Pharmacoeconomics, 2, 15-33.
29. Griffiths K, King DJ, Geddes GL, Moore G, Smith JC. (1982) WHO group reports on drug utilisation. Pharmacy Journal, 229, 107-109.
30. Cotterell CC, Dombroske L, Fischermann EA. (1991) Comprehensive drug-use evaluation program in a health maintenance organization. American Journal of Hospital Pharmacy, 48, 1712-1717.
31. Todd MW, Keith TD, Foster MT. (1987) Development and implementation of a comprehensive, criteria-based drug-use review program. American Journal of Hospital Pharmacy, 44, 529-535.
32. Briceland LL, Quintiliani R, Nightingale CH. (1988) Multidisciplinary cost-containment program promoting oral metronidazole for treatment of antibiotic associated colitis. American Journal of Hospital Pharmacy, 45, 122-125.
33. Wolfson DJ. (1980) Financial implications of a set of antibiotics policies. Pharmaceutical Journal, 224, 706-707.
34. Roark MK, Reed WE. (1995) Econotherapeutics. Diagnostic Microbiology and Infections Disease, 995, 209-217.
35. Capers CC, Bess DT, Branam AC, et al. (1993) Antibiotic surveillance: the results of a clinical pharmacy intervention program. Hospital Pharmacy, 28, 212.
36. Hess DA, Mahoney CD, Johnson PN, Corrao WM, Fisher AE. (1990) Integration of clinical and administrative strategies to reduce expenditures for antimicrobial agents. American Journal of Hospital Pharmacy, 47, 585-591.
37. Manzo J, Amodio-Groton MA, Kleinmann MS. (1993) Antibiotic cost control measures in a hospital pharmacy. Clinical Therapeutics, 15, 37-43.
38. Dzierba SH, Reilly RT, Caselnova III DA. (1986) Cost savings achieved through cephalosporin use review and restriction. American Journal of Hospital Pharmacy, 43, 2194-2197.
39. Gould IM, Hampson J, Taylor EW, Wood MJ. (1994) Hospital antibiotic control measures in the UK-Working Party of the British Society for Antimicrobial Chemotherapy. Journal of Antimicrobial Chemotherapy, 34, 21-42.
40. Gould IM, Jappy B. (1996) Trends in hospital antibiotic prescribing after introduction of an antibiotic policy. Journal of Antimicrobial Chemotherapy, 38, 895-904.
41. Rifenburg RP, Paladino JA, Hanson SC, Tuttle JA, Schentag JJ. (1996) Benchmark analysis of strategies hospitals use to control antimicrobial expenditure. American Journal of Health-Systems Pharmacy, 53, 2054-2062.
42. Tritschler I. (1997) How pharmacists can help in rationalising antibiotic prescribing in hospitals. Hospital Pharmacist, 4, 202-204.
43. Rich DS. (1989) Experience with a two-tiered therapeutic interchange policy. American Journal of Hospital Pharmacy, 46, 1792-1798.
44. Oh T, Franko TG. (1991) Comprehensive therapeutic interchange program in a community hospital. American Journal of Hospital Pharmacy, 48, 1471-1477.
45. Rawlings RD. (1995) Therapeutic exchange of cefotaxime for ceftriaxone: evaluation, implementation and subsequent cost savings at a 300-bed community hospital. Diagnostic Microbiology and Infectious Disease, 22, 235-237.
46. Mulholland PJ. (1995) Drug interchange cuts costs-flouroquinolone interchange: a hospital policy change with community implications. Pharmacy in Practice, 5, 341-343.
47. Achusim LE. (1992) Therapeutic interchange as a cost-containment measure. Pharmacoeconomics, 2, 347-351.
48. Shulman SR, Gouveia W. (1993) Therapeutic substitution on option for cost effective prescribing? Pharmacoeconomics, 3, 257-259.
49. Read C. (1993) Put pharmacists in the front seat. Health-care Management, 1, 32-34.
50. Montazeri M, Cook DJ. (1994) Impact of a clinical pharmacist in a multidisciplinary intensive care unit. Critical Care Medicine, 22, 1044-1048.
51. Catania HF, Yee WP, Catania PN. (1990) Four years' experience with a clinical intervention program: cost avoidance and impact of a clinical co-ordinator. American Journal of Hospital Pharmacy, 47, 2701-2705.
52. ASHP (1992) Technical assistance bulletin on assessing cost-containment strategies for pharmacies in organized health-care settings. American Journal of Hospital Pharmacy, 49, 155-160.
53. Langley PC. (1995) Pharmacoeconomics and the quality of decision-making by pharmacy and therapeutics committees. American Journal of Health-Systems Pharmacy, 52, S24-26.
54. ABPI and Department of Health Guidance on good practice in the conduct of economic evaluations of medicines. 20 May,1994. Association of British Pharmaceutical Industry, London.
55. Bloor K, Freemantle N. (1997) Promoting Cost-effective Prescribing in the UK National Health Sercice. Centre for Health Economics, University of York Publications Office, York.
56. Mason J, Drummond M. (1995) Reporting guidelines for economic studies. Health Economics, 4, 85-94.
57. Drummond MF, Jefferson TO. (1996) Guidelines for authors and peer reviewers of economic submissions to the BMJ. British Medical Journal, 313, 275-283.
58. Karr A. (1994) Improving the drug evaluation process. Pharmacy Journal, 252, 576-577.
59. Janknegt R, Wijnands WJA, Stobberingh E. (1996) Antibiotics in lower respiratory tract infections. European Hospital Pharmacy, 2, 64-71.
60. Janknegt R, Van Schaik B, Smits J, DeLeeuw PW. (1997) ACE inhibitors and angiotensin II antagonists for the treatment of hypertension: drug selection by means of the Soja method. European Hospital Pharmacy, 3, 46-58.
61. Narayan A, Critchlow H, Standing VF, Kaye D. (1996) A survey to determine the level of drug cost awareness amongst hospital consultants. Pharmacy Management, 12, 37-38.
62. Ward CA. (1993) How to meet directorates' needs -developing a pharmacy information strategy - the integration of an executive information system and clinical pharmacy skills. Hospital Pharmacy Practice, 3, 503-506.
63. Wilson M, Wallis K, Beech E, Brown L. (1991) Clinical directorates and the hospital pharmacist. Pharmacy Journal, 247, HS 25-26.
64. Hughes KR, Brown N, Armstrong RF, Bullen C. (1990) Pharmaceutical expenditure in intensive care. Clinical Intensive Care, 1, 12-16.
65. Lee KR, Kothanur R. (1994) Controlling high-cost drug use (letter). American Journal of Hospital Pharmacy, 51, 118-122.
66. Department of Health. (1989) Working for Patients. HMSO, London.
67. NHS Management Executive/Department of Health EL(93)115. (1993) Improving clinical effectiveness. DoH, London.
68. Plumridge RJ. (1983) A review of factors influencing drug prescribing (Part 1). Australian Journal of Hospital Pharmacy, 13, 16-19.
69. Plumridge RJ. (1983) A review of factors influencing drug prescribing (Part 2). Australian Journal of Hospital Pharmacy, 13, 44-48.
70. Plumridge RJ. (1984) Intervention strategies aimed at modifying prescribing behaviour. Australian Journal of Hospital Pharmacy, 14, 93-100.
71. Avorn J, Soumerai SB. (1983) Improving drug-therapy decisions through educational outreach - a randomized controlled trial of academically based 'detailing'. New England Journal of Medicine, 308, 1457-1463.
72. Eckert GM, Ioannides-Demos LL, McLean AJ. (1991) Measuring and modifying hospital drug use. Medicine Journal of Australia, 154, 587-592.
73. Greco PJ, Eisenberg JM. (1993) Changing physicians practices. New England Journal of Medicine, 329, 271-274.